Rapid desensitization of the serotonin2C receptor system:: Effector pathway and agonist dependence

被引:53
作者
Stout, BD [1 ]
Clarke, WP [1 ]
Berg, KA [1 ]
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Pharmacol, San Antonio, TX 78229 USA
关键词
D O I
10.1124/jpet.302.3.957
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The serotonin(2C) (5-HT2C) receptor couples to multiple effector mechanisms, including phospholipase A(2)-mediated arachidonic acid (AA) release and phospholipase C-mediated production of inositol phosphates (IP). Agonist relative efficacy differs depending upon which response (AA release or IP accumulation) is measured. In this study, we investigated the characteristics and agonist dependence of rapid desensitization of 5-HT2C receptor-mediated AA release and IP accumulation measured simultaneously from the same cell population. Pretreatment with 5-HT reduced the ability of a maximal concentration of 5-HT to elicit AA release and IP accumulation by about 60%; however, the AA response desensitized more rapidly (t(1/2) + 1.3 min) than the IP response (t(1/2) + 6.9 min). In addition, desensitization of the IP response was more sensitive (occurred at lower receptor occupancy levels) than the AA response. Moreover, in response to submaximal 5-HT concentrations, after an initial transient desensitization, the AA response was enhanced by up to similar to250%. After maximal desensitization, both responses recovered, but recovery of the AA response was complete and faster than that for IP. Desensitization of both responses was also agonist-dependent, and the capacity of agonists to elicit desensitization was not related to their efficacy to activate signaling. These data suggest that desensitization of the 5- HT2C receptor system is both agonist- and effector pathway-dependent and underscore the need to study multiple cellular responses to multiple agonists to understand receptor-mediated signaling systems.
引用
收藏
页码:957 / 962
页数:6
相关论文
共 35 条
[1]   Role of phospholipase C beta 3 phosphorylation in the desensitization of cellular responses to platelet-activating factor [J].
Ali, H ;
Fisher, I ;
Haribabu, B ;
Richardson, RM ;
Snyderman, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (18) :11706-11709
[2]   BETA-ADRENERGIC-RECEPTOR KINASE - IDENTIFICATION OF A NOVEL PROTEIN-KINASE THAT PHOSPHORYLATES THE AGONIST-OCCUPIED FORM OF THE RECEPTOR [J].
BENOVIC, JL ;
STRASSER, RH ;
CARON, MG ;
LEFKOWITZ, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (09) :2797-2801
[3]  
BERG KA, 1994, MOL PHARMACOL, V46, P477
[4]  
Berg KA, 2001, J PHARMACOL EXP THER, V299, P593
[5]   RNA-editing of the 5-HT2C receptor alters agonist-receptor-effector coupling specificity [J].
Berg, KA ;
Cropper, JD ;
Niswender, CM ;
Sanders-Bush, E ;
Emeson, RB ;
Clarke, WP .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (02) :386-392
[6]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[7]   MOLECULAR-BIOLOGY OF 5-HT RECEPTORS [J].
BOESS, FG ;
MARTIN, IL .
NEUROPHARMACOLOGY, 1994, 33 (3-4) :275-317
[8]   Comparative desensitization of the human 5-HT2A and 5-HT2C receptors expressed in the human neuroblastoma cell line SH-SY5Y [J].
Briddon, SJ ;
Leslie, RA ;
Elliott, JM .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (04) :727-734
[9]  
Brink CB, 2000, J PHARMACOL EXP THER, V294, P539
[10]   The elusive nature of intrinsic efficacy [J].
Clarke, WP ;
Bond, RA .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1998, 19 (07) :270-276